Effective treatment relies on accurate identification of tumor origin
In this era of targeted therapies, it is more critical than ever to begin with an accurate diagnosis. However, many diagnostics currently in use are inadequate
1. Until now, there has been an unmet need for accurate and time-efficient testing to determine primary origin.
miRview™ mets is the first microRNA-based molecular diagnostic test designed for cancer of unknown primary (CUP). It offers:
- Accuracy
- Efficiency
- Validity
- Simple interpretation
- Quantitative analysis
- Objective results
- Cutting-edge molecular biology
- Varadhachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer. 2004;100(9):1776-1785.
